Bioprocess development of antibody-drug conjugate production for cancer treatment
Bioprocess development of antibody-drug conjugate production for cancer treatment
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Antibody-drug conjugate (ADC) is a class of targeted cancer therapies that combine the advantages of monoclonal antibody (mAb)'s specific targeting and chemotherapy's potent cytotoxicity. The therapeutic effect of ADC is significantly affected by its bioproduction process. This study aims to develop an effective ADC production process using anti-HE...
Alternative Titles
Full title
Bioprocess development of antibody-drug conjugate production for cancer treatment
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2124452666
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2124452666
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0206246
